TY - JOUR
T1 - Association between mentally stimulating activities in late life and the outcome of incident mild cognitive impairment, with an analysis of the APOE ϵ4 genotype
AU - Krell-Roesch, Janina
AU - Vemuri, Prashanthi
AU - Pink, Anna
AU - Roberts, Rosebud O.
AU - Stokin, Gorazd B.
AU - Mielke, Michelle M.
AU - Christianson, Teresa J.H.
AU - Knopman, David S.
AU - Petersen, Ronald C.
AU - Kremers, Walter K.
AU - Geda, Yonas E.
N1 - Funding Information:
The study was supported by grants U01 AG006786 and R01 AG034676 from the National Institute on Aging and by grants K01 MH068351 and K01 AG028573 from the National Institute of Mental Health. Support for this research was also provided by the RobertWood Johnson Foundation, the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program, the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/ 02.0123), the Arizona Alzheimer's Consortium, and the Edli Foundation (the Netherlands) (Dr Geda).
Publisher Copyright:
© 2017 American Medical Association.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - IMPORTANCE Cross-sectional associations between engagement in mentally stimulating activities and decreased odds of having mild cognitive impairment (MCI) or Alzheimer disease have been reported. However, little is known about the longitudinal outcome of incident MCI as predicted by late-life (aged ≥70 years) mentally stimulating activities. OBJECTIVES To test the hypothesis of an association between mentally stimulating activities in late life and the risk of incident MCI and to evaluate the influence of the apolipoprotein E (APOE) ϵ4 genotype. DESIGN, SETTING, AND PARTICIPANTS This investigationwas a prospective, population-based cohort study of participants in the Mayo Clinic Study of Aging in Olmsted County, Minnesota. Participants 70 years or older who were cognitively normal at baseline were followed up to the outcome of incident MCI. The study dates were April 2006 to June 2016. MAIN OUTCOMES AND MEASURES At baseline, participants provided information about mentally stimulating activities within 1 year before enrollment into the study. Neurocognitive assessment was conducted at baseline, with evaluations at 15-month intervals. Cognitive diagnosis was made by an expert consensus panel based on published criteria. Hazard ratios (HRs) and 95%CIs were calculated using Cox proportional hazards regression models after adjusting for sex, age, and educational level. RESULTS The final cohort consisted of 1929 cognitively normal persons (median age at baseline, 77 years [interquartile range, 74-82 years]; 50.4%[n = 973] female) who were followed up to the outcome of incident MCI. During a median follow-up period of 4.0 years, it was observed that playing games (HR, 0.78; 95%CI, 0.65-0.95) and engaging in craft activities (HR, 0.72; 95%CI, 0.57-0.90), computer use (HR, 0.70; 95%CI, 0.57-0.85), and social activities (HR, 0.77; 95%CI, 0.63-0.94) were associated with a decreased risk of incident MCI. In a stratified analysis by APOE ϵ4 carrier status, the data point toward the lowest risk of incident MCI for APOE ϵ4 noncarriers who engage in mentally stimulating activities (eg, computer use: HR, 0.73; 95%CI, 0.58-0.92) and toward the highest risk of incident MCI for APOE ϵ4 carriers who do not engage in mentally stimulating activities (eg, no computer use: HR, 1.74; 95%CI, 1.33-2.27). CONCLUSIONS AND RELEVANCE Cognitively normal elderly individuals who engage in specific mentally stimulating activities even in late life have a decreased risk of incident MCI. The associations may vary by APOE ϵ4 carrier status.
AB - IMPORTANCE Cross-sectional associations between engagement in mentally stimulating activities and decreased odds of having mild cognitive impairment (MCI) or Alzheimer disease have been reported. However, little is known about the longitudinal outcome of incident MCI as predicted by late-life (aged ≥70 years) mentally stimulating activities. OBJECTIVES To test the hypothesis of an association between mentally stimulating activities in late life and the risk of incident MCI and to evaluate the influence of the apolipoprotein E (APOE) ϵ4 genotype. DESIGN, SETTING, AND PARTICIPANTS This investigationwas a prospective, population-based cohort study of participants in the Mayo Clinic Study of Aging in Olmsted County, Minnesota. Participants 70 years or older who were cognitively normal at baseline were followed up to the outcome of incident MCI. The study dates were April 2006 to June 2016. MAIN OUTCOMES AND MEASURES At baseline, participants provided information about mentally stimulating activities within 1 year before enrollment into the study. Neurocognitive assessment was conducted at baseline, with evaluations at 15-month intervals. Cognitive diagnosis was made by an expert consensus panel based on published criteria. Hazard ratios (HRs) and 95%CIs were calculated using Cox proportional hazards regression models after adjusting for sex, age, and educational level. RESULTS The final cohort consisted of 1929 cognitively normal persons (median age at baseline, 77 years [interquartile range, 74-82 years]; 50.4%[n = 973] female) who were followed up to the outcome of incident MCI. During a median follow-up period of 4.0 years, it was observed that playing games (HR, 0.78; 95%CI, 0.65-0.95) and engaging in craft activities (HR, 0.72; 95%CI, 0.57-0.90), computer use (HR, 0.70; 95%CI, 0.57-0.85), and social activities (HR, 0.77; 95%CI, 0.63-0.94) were associated with a decreased risk of incident MCI. In a stratified analysis by APOE ϵ4 carrier status, the data point toward the lowest risk of incident MCI for APOE ϵ4 noncarriers who engage in mentally stimulating activities (eg, computer use: HR, 0.73; 95%CI, 0.58-0.92) and toward the highest risk of incident MCI for APOE ϵ4 carriers who do not engage in mentally stimulating activities (eg, no computer use: HR, 1.74; 95%CI, 1.33-2.27). CONCLUSIONS AND RELEVANCE Cognitively normal elderly individuals who engage in specific mentally stimulating activities even in late life have a decreased risk of incident MCI. The associations may vary by APOE ϵ4 carrier status.
UR - http://www.scopus.com/inward/record.url?scp=85011267727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011267727&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2016.3822
DO - 10.1001/jamaneurol.2016.3822
M3 - Article
C2 - 28135351
AN - SCOPUS:85011267727
SN - 2168-6149
VL - 74
SP - 332
EP - 338
JO - JAMA Neurology
JF - JAMA Neurology
IS - 3
ER -